Zepp Health Corporation - ADR earnings per share and revenue
On Nov 04, 2025, ZEPP reported earnings of -0.04 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 75.79 million, compared to an expected --, with a --% difference. The market reacted with a -4.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
FAQ
What were Zepp Health Corporation - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zepp Health Corporation - ADR reported EPS of -$0.04, missing estimates by --, and revenue of $75.79M, -- -- expectations.
How did the market react to Zepp Health Corporation - ADR's Q3 2025 earnings?
The stock price moved down -4.7%, changed from $38.90 before the earnings release to $37.07 the day after.
When is Zepp Health Corporation - ADR expected to report next?
The next earning report is scheduled for Mar 24, 2026.
What are the forecasts for Zepp Health Corporation - ADR's next earnings report?
Based on --
analysts, Zepp Health Corporation - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.